SU-FF-J-62: Evolution of Tumor Volume and Motion in Non-Small Cell Lung Cancer During Radiotherapy

2006 ◽  
Vol 33 (6Part5) ◽  
pp. 2034-2034
Author(s):  
E Ford ◽  
D Song ◽  
E Tryggestad ◽  
T McNutt ◽  
J Wong
Keyword(s):  
Lung Cancer ◽  
Small Cell Lung Cancer ◽  
Cell Lung Cancer ◽  
Tumor Volume ◽  
Small Cell ◽  
Small Cell Lung

scholarly journals Tumor volume shrinkage during stereotactic body radiotherapy is related to better prognoses in patients with stage I non-small-cell lung cancer

2020 ◽  
Vol 61 (5) ◽  
pp. 740-746
Author(s):  
Nam Vu ◽  
Hiroshi Onishi ◽  
Masahide Saito ◽  
Kengo Kuriyama ◽  
Takafumi Komiyama ◽  
...  
Keyword(s):  
Lung Cancer ◽  
Overall Survival ◽  
Small Cell Lung Cancer ◽  
Local Control ◽  
Cell Lung Cancer ◽  
Tumor Volume ◽  
Small Cell ◽  
Stage I ◽  
Small Cell Lung ◽  
Volume Changes

Abstract The purpose of the study was to investigate the association between tumor volume changes during stereotactic body radiation therapy (SBRT) and prognoses in stage I non-small-cell lung cancer (NSCLC). This retrospective review included stage I NSCLC patients in whom SBRT was performed at a total dose of 48.0–50.5 Gy in four or five fractions. The tumor volumes observed on computed tomography (CT) simulation and on the CT performed at the last treatment session using a CT-on-rails system were measured and compared. Then, the tumor volume changes during the SBRT period were measured and assessed for their association with prognoses (overall survival, local control, lymph node metastases and distant metastases). A total of 98 patients with a mean age of 78.6 years were enrolled in the study. The T-stage was T1a in 42%, T1b in 32% and T2a in 26% of the cases. The gross tumor volume (GTV) shrank and increased ≥10% in 23 (23.5%) and 36 (36.7%) of the cases, respectively. The 5-year local control and overall survival rates in the groups with a tumor shrinkage of ≥10% vs the group with a shrinkage of <10% were 94.7 vs 70.8% and 85.4 vs 47.6%, respectively; these differences were significant, with a P-value < 0.05. During a short SBRT period, the tumor shrank or enlarged in a small number of cases. A decrease of ≥10% in the GTV during SBRT was significantly related to better overall survival and local control.

Reduction of Tumor Volume During Radiation for Non-Small Cell Lung Cancer (NSCLC)

2007 ◽  
Vol 69 (3) ◽  
pp. S507
Author(s):  
J.L. Fox ◽  
E. Ford ◽  
K. Janson ◽  
J. Zhou ◽  
L. Myers ◽  
...  
Keyword(s):  
Lung Cancer ◽  
Small Cell Lung Cancer ◽  
Cell Lung Cancer ◽  
Tumor Volume ◽  
Small Cell ◽  
Small Cell Lung

scholarly journals The Prognostic Impact of Tumor Volume in Patients with Clinical Stage IA Non–Small Cell Lung Cancer

2016 ◽  
Vol 11 (7) ◽  
pp. 1074-1080 ◽  
Author(s):  
Tomoyoshi Takenaka ◽  
Koji Yamazaki ◽  
Naoko Miura ◽  
Ryo Mori ◽  
Sadanori Takeo
Keyword(s):  
Lung Cancer ◽  
Small Cell Lung Cancer ◽  
Cell Lung Cancer ◽  
Tumor Volume ◽  
Clinical Stage ◽  
Small Cell ◽  
Prognostic Impact ◽  
Small Cell Lung ◽  
Clinical Stage Ia ◽  
Stage Ia

The Value of Tumor Volume in Surgically Resected Non-Small Cell Lung Cancer

2006 ◽  
Vol 54 (2) ◽  
pp. 112-116 ◽  
Author(s):  
A. Iwasaki ◽  
T. Shirakusa ◽  
S. Enatsu ◽  
S. Maekawa ◽  
T. Hamada ◽  
...  
Keyword(s):  
Lung Cancer ◽  
Small Cell Lung Cancer ◽  
Cell Lung Cancer ◽  
Tumor Volume ◽  
Small Cell ◽  
Small Cell Lung

The prognostic impact of tumor volume on stage I non-small cell lung cancer

Lung Cancer ◽  
2017 ◽  
Vol 104 ◽  
pp. 91-97 ◽  
Author(s):  
Xiao-Dong Su ◽  
Hao-Jun Xie ◽  
Qian-Wen Liu ◽  
Yun-Xian Mo ◽  
Hao Long ◽  
...  
Keyword(s):  
Lung Cancer ◽  
Small Cell Lung Cancer ◽  
Cell Lung Cancer ◽  
Tumor Volume ◽  
Small Cell ◽  
Stage I ◽  
Prognostic Impact ◽  
Small Cell Lung
Sign in / Sign up

Export Citation Format

Share Document